Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkem Laboratories Limited Call Transcript 2025

Jan 30, 2025

61611_rns_2025-01-30_4dc20a1c-d3ec-4c98-936e-22fd1a6090c1.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [595 x 128] intentionally omitted <==

30[th] January, 2025

To,

The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM

Sub: Intimation of Conference Call on Q3FY25

Dear Sir(s) / Madam,

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY25 financial results will be held on Friday, 07[th] February, 2025 at 04.00 p.m.

Please find attached herewith the conference call details.

Kindly take note of the same.

Sincerely, For Alkem Laboratories Limited

MANISH Digitally signed by MANISH NARANG NARANG Date: 2025.01.30 13:05:09 +05'30'

Manish Narang President – Legal, Company Secretary & Compliance Officer

==> picture [595 x 130] intentionally omitted <==

Invite for Q3FY25 Conference Call at 4.00 pm IST, February 07, 2025

Mumbai, January 30, 2025: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Friday, February 07, 2025, from 4:00 pm to 5:00 pm IST to discuss its Q3FY25 financial results. The call will follow the announcement of the Company’s Q3FY25 financial results on Friday, February 07, 2025.

Alkem Laboratories Ltd. will be represented on the call by:

Dr. Vikas Gupta – CEO Mr. Nitin Agrawal – CFO

Motilal Oswal Securities Ltd. will host the call.

Details of the conference call are as follows:

Time: 4:00 pm IST (GMT + 5:30) on Friday, February 07, 2025.

Dial in Details:

India: +91 22 6280 1149 / +91 22 7115 8050

International Toll-Free

USA : 1 866 746 2133 UK : 0 808 101 1573 Singapore : 800 101 2045 Hong Kong : 800 964 448

Express Join with Diamond Pass

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=23323 24&linkSecurityString=102d9acd80

You are requested to dial in 10 mins ahead of the scheduled start time.

Purvi Shah / Isha Trivedi Tushar Manudhane Investor Relations / Media Institutional Research Analyst - Healthcare Alkem Laboratories Ltd. Motilal Oswal Securities Ltd. Mobile: +91 84337 00890 / 98925 90003 Tel.: +91 22 6129 1536 / +91 82911 38039 Tel.: +91 22 3982 9999 Ext: 9447 E-mail: [email protected] E-mail: [email protected]/ [email protected]